$PRAX

Praxis Precision Medicines Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Major

PRICE

$9.12 ▲0.551%

Delayed Price

VOLUME

59,909

DAY RANGE

-

52 WEEK

7.25 - 23.56

Join Discuss about PRAX with like-minded investors

profile
@dros #droscrew
recently

Positive Initiations 11/10: $A $ABBV $ALGS $ASAN $BLFS $BLI $BMRA $BRKS $CDMO $CSTL $CYRX $DHR $EAR $HBIO $OCX $PLAN $PRAX $RGEN $SYRS $TARS $VRM $WK $WST $XGN

90 Replies 9 👍 6 🔥

Key Metrics

Market Cap

412.79 M

Beta

1.58

Avg. Volume

473.41 K

Shares Outstanding

45.51 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-09

Next Dividend Date

Company Information

Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance. Praxis is applying insights from genetic epilepsies to broader neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain. Praxis has established a broad portfolio, including multiple disclosed programs across CNS disorders including depression, epilepsy, movement disorders and pain syndromes, with three clinical-stage product candidates.

Website:

HQ: ,

Related News